|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: VIANT CORP, 10-Q, 2000-11-13 |
Next: BIOENVISION INC, 10KSB40, 2000-11-13 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-29-2000
<PERIOD-END> SEP-29-2000
<CASH> 151,446
<SECURITIES> 43,047
<RECEIVABLES> 30,345
<ALLOWANCES> 2,532
<INVENTORY> 0
<CURRENT-ASSETS> 223,638
<PP&E> 18,443
<DEPRECIATION> (5,995)
<TOTAL-ASSETS> 244,239
<CURRENT-LIABILITIES> 30,975
<BONDS> 1,031
0
0
<COMMON> 48
<OTHER-SE> 212,185
<TOTAL-LIABILITY-AND-EQUITY> 244,239
<SALES> 0
<TOTAL-REVENUES> 102,211
<CGS> 0
<TOTAL-COSTS> 44,084
<OTHER-EXPENSES> 54,175
<LOSS-PROVISION> 2,744
<INTEREST-EXPENSE> 163
<INCOME-PRETAX> 12,187
<INCOME-TAX> 1,473
<INCOME-CONTINUING> 10,714
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 10,714
<EPS-BASIC> 0.23
<EPS-DILUTED> 0.19
</TABLE>
|
|